Advanced search
Publication Cover
Journal of Medical Economics Volume 24, 2021 - Issue 1
Submit an article Journal homepage
4,820
Views
3
CrossRef citations to date
0
Altmetric
Neurology

Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia

Michael L. Ganza Real-world Evidence, Evidera, Waltham, MA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9702-2999
ORCID Icon,
Ameya Chavanb Evidence Synthesis, Modeling & Communication, Evidera, Bethesda, MD, USA
,
Rahul Dhandac Neurocrine Biosciences, Inc, San Diego, CA, USAORCID Iconhttps://orcid.org/0000-0002-6941-3853
ORCID Icon,
Michael Serbinc Neurocrine Biosciences, Inc, San Diego, CA, USAORCID Iconhttps://orcid.org/0000-0001-6876-7150
ORCID Icon &
Charles Yonanc Neurocrine Biosciences, Inc, San Diego, CA, USA
Pages 103-113 | Received 17 Sep 2020, Accepted 09 Dec 2020, Published online: 20 Jan 2021

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.